Health One, Inc. – Trademark Portfolio
Entity Type: 03
Health One, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include UVANTA, INQUIRELABS, LTCADVANTAGE, PHARMACY SERVICES BUILT AROUND YOU, and THE CARE OF ONE. THE STRENGTH OF MANY.. The owner is based in Appleton, WI.
1050 S. Grider Street, Ste. B
Appleton, WI 54914
Showing of trademarks Trademarks
Trademark Classifications
Health One, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Health One, Inc. have?
Health One, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned.
What trademark classes does Health One, Inc. file in?
Health One, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 35 (Advertising & Business). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Health One, Inc.'s most well-known trademarks?
Health One, Inc.'s registered trademark portfolio includes well-known marks such as UVANTA, INQUIRELABS, LTCADVANTAGE, PHARMACY SERVICES BUILT AROUND YOU, and THE CARE OF ONE. THE STRENGTH OF MANY.. These are among 6 currently registered trademarks in the portfolio.
What is Health One, Inc.'s trademark registration success rate?
Health One, Inc. has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.